RT Journal Article
T1 Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial.
A1 Dam, Tien
A1 Boxer, Adam L
A1 Golbe, Lawrence I
A1 Höglinger, Günter U
A1 Morris, Huw R
A1 Litvan, Irene
A1 Lang, Anthony E
A1 Corvol, Jean-Christophe
A1 Aiba, Ikuko
A1 Grundman, Michael
A1 Yang, Lili
A1 Tidemann-Miller, Beth
A1 Kupferman, Joseph
A1 Harper, Kristine
A1 Kamisoglu, Kubra
A1 Wald, Michael J
A1 Graham, Danielle L
A1 Gedney, Liz
A1 O'Gorman, John
A1 Haeberlein, Samantha Budd
A1 PASSPORT Study Group, 
YR 2022
FD 2022-10-17
LK http://hdl.handle.net/10668/19574
UL http://hdl.handle.net/10668/19574
LA en
DS RISalud
RD Apr 12, 2025